consulting fees from NovoNordisk, Eli Lilly, Johnson&Johnson, Boehringer Ingelheim, GI Dynamics, Herbalife, Altimmune, Irish Life Health, Amgen, Arrowhead, Roche, AstraZeneca, Keyron, Gila Pharmaceuticals, Metsera, Nymble, AbbVie, and Olympus
Zepbound is approved for adults only) [12] [13] Previous unsuccessful attempts at weight loss through lifestyle modification Certain medical conditions may preclude the use of weight loss injections
Miterko LN, Sillitoe RV, Hawkes R
Clinical trials have demonstrated average A1C reductions ranging from 1.5% to 2.0%, with some patients achieving greater improvements depending on baseline glucose control, lifestyle factors, and medication adherence